Clinical Trials
2 trialsNCT06980038 2026-05-13
Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer
National Cancer Institute (NCI)
Phase 2 Recruiting
NCT06338657 2025-09-16
FID-007 Followed by Standard of Care Surgery in Head and Neck Cancer
University of Southern California
Phase 1 Terminated